Skip to main content
Top
Published in: World Journal of Urology 10/2015

01-10-2015 | Original Article

Prognostic value of systemic inflammatory responses in patients with upper urinary tract urothelial carcinoma

Authors: Myong Kim, Kyung Chul Moon, Woo Suk Choi, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, Ja Hyeon Ku

Published in: World Journal of Urology | Issue 10/2015

Login to get access

Abstract

Purpose

To determine the utility of systemic inflammatory response and develop a model based on serum inflammatory indices to aid prognostication in patients with upper urinary tract urothelial carcinoma (UTUC).

Methods

The study population comprised 277 patients with non-metastatic UTUC who underwent nephroureterectomy between 1999 and 2010. Multivariate survival analysis was performed using Cox’s proportional hazards model, and a new model was developed to predict recurrence-free (RFS) and disease-specific survival (DSS). The factors considered, in relation to systemic inflammatory responses, were as follows: albumin, white blood cell count, neutrophil count, lymphocyte count, red blood cell count, serum creatinine level, platelet count, prognostic nutritional index, platelet/lymphocyte ratio, neutrophil/lymphocyte ratio (NLR), and derived NLR.

Results

The final model consisted of bladder cuffing, pathologic T stage, lymphovascular invasion, and derived NLR. The bootstrap-concordance indices of the model were 0.778 [95 confidence interval (CI) 0.730–0.826] for RFS and 0.802 (95 % CI 0.752–0.851) for DSS, respectively, and integrated area under the curve value for time to RFS and DSS for patients was 0.738 and 0.760, respectively. When we generated calibration curves, the nomograms were reasonably calibrated.

Conclusions

Derived NLR may be used in combination with conventional staging techniques and other clinicopathological parameters to improve the prediction of survival in patients with UTUC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249CrossRefPubMed Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249CrossRefPubMed
2.
go back to reference Raman JD, Scherr DS (2007) Management of patients with upper urinary tract transitional cell carcinoma. Nat Clin Pract Urol 4:432–443CrossRefPubMed Raman JD, Scherr DS (2007) Management of patients with upper urinary tract transitional cell carcinoma. Nat Clin Pract Urol 4:432–443CrossRefPubMed
3.
go back to reference Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, The Upper Tract Urothelial Carcinoma Collaboration et al (2009) Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 115:1224–1233CrossRefPubMed Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, The Upper Tract Urothelial Carcinoma Collaboration et al (2009) Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 115:1224–1233CrossRefPubMed
4.
go back to reference Novara G, De Marco V, Gottardo F, Dalpiaz O, Bouygues V, Galfano A et al (2007) Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer 110:1715–1722CrossRefPubMed Novara G, De Marco V, Gottardo F, Dalpiaz O, Bouygues V, Galfano A et al (2007) Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer 110:1715–1722CrossRefPubMed
6.
go back to reference Glen P, Jamieson NB, McMillan DC, Carter R, Imrie CW, McKay CJ (2006) Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer. Pancreatology 6:450–453CrossRefPubMed Glen P, Jamieson NB, McMillan DC, Carter R, Imrie CW, McKay CJ (2006) Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer. Pancreatology 6:450–453CrossRefPubMed
7.
go back to reference Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448–454CrossRefPubMed Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448–454CrossRefPubMed
8.
go back to reference Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, Steering Committee of the European Association for Palliative Care et al (2005) Prognostic factors in advanced cancer patients: evidence-based clinical recommendations-a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 23:6240–6248CrossRefPubMed Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, Steering Committee of the European Association for Palliative Care et al (2005) Prognostic factors in advanced cancer patients: evidence-based clinical recommendations-a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 23:6240–6248CrossRefPubMed
9.
go back to reference Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O’Reilly DSJ et al (2011) A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study. Eur J Cancer 47:2633–2641CrossRefPubMed Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O’Reilly DSJ et al (2011) A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study. Eur J Cancer 47:2633–2641CrossRefPubMed
10.
go back to reference Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 85:1001–1005PubMed Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 85:1001–1005PubMed
11.
go back to reference Smith RA, Bosonnet L, Raraty M, Sutton R, Neoptolemos JP, Campbell F et al (2009) Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg 197:466–472CrossRefPubMed Smith RA, Bosonnet L, Raraty M, Sutton R, Neoptolemos JP, Campbell F et al (2009) Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg 197:466–472CrossRefPubMed
12.
go back to reference Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ (2005) Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91:181–184CrossRefPubMed Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ (2005) Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91:181–184CrossRefPubMed
13.
go back to reference Gondo T, Nakashima J, Ohno Y, Choichiro O, Horiguchi Y, Namiki K et al (2012) Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy. Urology 79:1085–1091CrossRefPubMed Gondo T, Nakashima J, Ohno Y, Choichiro O, Horiguchi Y, Namiki K et al (2012) Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy. Urology 79:1085–1091CrossRefPubMed
14.
go back to reference Proctor MJ, McMillan DC, Morrison DS, Fletcher CD, Horgan PG, Clarke SJ (2012) A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer 107:695–699PubMedCentralCrossRefPubMed Proctor MJ, McMillan DC, Morrison DS, Fletcher CD, Horgan PG, Clarke SJ (2012) A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer 107:695–699PubMedCentralCrossRefPubMed
15.
go back to reference Todenhöfer T, Renninger M, Schwentner C, Stenzl A, Gakis G (2012) A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors. BJU Int 110:E533–540CrossRefPubMed Todenhöfer T, Renninger M, Schwentner C, Stenzl A, Gakis G (2012) A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors. BJU Int 110:E533–540CrossRefPubMed
16.
go back to reference Hashimoto T, Ohno Y, Nakashima J, Gondo T, Ohori M, Tachibana M (2013) Clinical significance of preoperative peripheral blood neutrophil count in patients with non-metastatic upper urinary tract carcinoma. World J Urol 31:953–958CrossRefPubMed Hashimoto T, Ohno Y, Nakashima J, Gondo T, Ohori M, Tachibana M (2013) Clinical significance of preoperative peripheral blood neutrophil count in patients with non-metastatic upper urinary tract carcinoma. World J Urol 31:953–958CrossRefPubMed
17.
go back to reference Lehmann J, Suttmann H, Kovac I, Hack M, Kamradt J, Siemer S et al (2007) Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival. Eur Urol 51:1281–1288CrossRefPubMed Lehmann J, Suttmann H, Kovac I, Hack M, Kamradt J, Siemer S et al (2007) Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival. Eur Urol 51:1281–1288CrossRefPubMed
18.
go back to reference Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ (2003) Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 89:1028–1030PubMedCentralCrossRefPubMed Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ (2003) Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 89:1028–1030PubMedCentralCrossRefPubMed
19.
go back to reference McMillan DC (2008) An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 67:257–262CrossRefPubMed McMillan DC (2008) An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 67:257–262CrossRefPubMed
20.
go back to reference Kasymjanova G, MacDonald N, Agulnik JS, Cohen V, Pepe C, Kreisman H et al (2010) The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer. Curr Oncol 17:52–58PubMedCentralCrossRefPubMed Kasymjanova G, MacDonald N, Agulnik JS, Cohen V, Pepe C, Kreisman H et al (2010) The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer. Curr Oncol 17:52–58PubMedCentralCrossRefPubMed
21.
go back to reference Ku JH, Kim M, Choi WS, Kwak C, Kim HH (2014) Preoperative serum albumin as a prognostic factor in patients with upper urinary tract urothelial carcinoma. Int Braz J Urol 40:753–762CrossRefPubMed Ku JH, Kim M, Choi WS, Kwak C, Kim HH (2014) Preoperative serum albumin as a prognostic factor in patients with upper urinary tract urothelial carcinoma. Int Braz J Urol 40:753–762CrossRefPubMed
22.
go back to reference Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361–387CrossRefPubMed Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361–387CrossRefPubMed
23.
go back to reference Heagerty PJ, Lumley T, Pepe MS (2000) Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56:337–544CrossRefPubMed Heagerty PJ, Lumley T, Pepe MS (2000) Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56:337–544CrossRefPubMed
25.
go back to reference Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30:1073–1081CrossRefPubMed Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30:1073–1081CrossRefPubMed
26.
go back to reference Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436–444CrossRefPubMed Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436–444CrossRefPubMed
27.
go back to reference Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M (2007) The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 73:215–220CrossRefPubMed Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M (2007) The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 73:215–220CrossRefPubMed
28.
go back to reference Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH (2003) Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 6:283–287CrossRefPubMed Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH (2003) Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 6:283–287CrossRefPubMed
29.
go back to reference Ding PR, An X, Zhang RX, Fang YJ, Li LR, Chen G et al (2010) Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer. Int J Colorectal Dis 25:1427–1433CrossRefPubMed Ding PR, An X, Zhang RX, Fang YJ, Li LR, Chen G et al (2010) Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer. Int J Colorectal Dis 25:1427–1433CrossRefPubMed
30.
go back to reference Hung HY, Chen JS, Yeh CY, Changchien C-R, Tang R, Hsieh P-S et al (2011) Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy. Int J Colorectal Dis 26:1059–1065CrossRefPubMed Hung HY, Chen JS, Yeh CY, Changchien C-R, Tang R, Hsieh P-S et al (2011) Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy. Int J Colorectal Dis 26:1059–1065CrossRefPubMed
31.
go back to reference McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12:223–226CrossRefPubMed McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12:223–226CrossRefPubMed
32.
go back to reference Richards CH, Roxburgh CS, MacMillan MT, Isswiasi S, Robertson EG, Guthrie GK et al (2012) The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer. PLoS ONE 7:e41883PubMedCentralCrossRefPubMed Richards CH, Roxburgh CS, MacMillan MT, Isswiasi S, Robertson EG, Guthrie GK et al (2012) The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer. PLoS ONE 7:e41883PubMedCentralCrossRefPubMed
Metadata
Title
Prognostic value of systemic inflammatory responses in patients with upper urinary tract urothelial carcinoma
Authors
Myong Kim
Kyung Chul Moon
Woo Suk Choi
Chang Wook Jeong
Cheol Kwak
Hyeon Hoe Kim
Ja Hyeon Ku
Publication date
01-10-2015
Publisher
Springer Berlin Heidelberg
Published in
World Journal of Urology / Issue 10/2015
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-015-1484-9

Other articles of this Issue 10/2015

World Journal of Urology 10/2015 Go to the issue